HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
This is the first Agilent lab to receive the My Green Lab Certification and plans are under way to certify additional labs.
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
Subscribe To Our Newsletter & Stay Updated
